Evidence map›Paper›PMID 36625743›Full record

ArticleRadiology2023

Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study.

Yoshimi Anzai, Chun-Pin Chang, Kerry Rowe, John Snyder, Vikrant Deshmukh, Michael Newman, Alison Fraser, Ken Smith, Ankita Date, Carlos Galvao and 2 more

Abstract read
In one paragraph

Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Surveillance after treatment for head and neck cancer.Current opinion in otolaryngology & head and neck surgery · 2026
    Review
  3. NI-RADS in posttreatment head and neck cancer surveillance: a framework for standardized imaging with clinical impact.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yoshimi AnzaiFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).ORCID 0000-0003-2988-7445
Chun-Pin ChangFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).
Kerry RoweFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).
John SnyderFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).
Vikrant DeshmukhFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).
Michael NewmanFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).ORCID 0000-0002-3147-6058
Alison FraserFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).ORCID 0000-0003-1681-698X
Ken SmithFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).
Ankita DateFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).ORCID 0000-0002-1792-9436
Carlos GalvaoFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).ORCID 0000-0002-1842-2311
Marcus MonroeFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).ORCID 0000-0001-8899-2304
Mia HashibeFrom the Huntsman Cancer Institute, Salt Lake City, Utah (Y.A., C.P.C., M.H.); Division of Public Health, Department of Family & Preventive Medicine (C.P.C., M.H.), Division of Otolaryngology, Department of Surgery (M.M.), and Department of Radiology and Imaging Sciences (Y.A.), University of Utah School of Medicine, 30N 1900 E, IA 71, Salt Lake City, UT 84102; Intermountain Healthcare, Salt Lake City, Utah (K.R., J.S.); University of Utah Health Sciences Center, Salt Lake City, Utah (V.D., M.N.); and Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah (A.F., K.S., A.D., C.G.).

Funding

NCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016I
6 · The paper itself

Abstract

Background To the knowledge of the authors, no strong evidence supports surveillance imaging in patients with head and neck cancer (HNC). Purpose To investigate the association between surveillance imaging and mortality using a population-based study design with statewide cancer registry data, all-payer claims data, and health care facility data. Materials and Methods The retrospective population-based study identified patients with HNC diagnosed between January 2012 and December 2017. Current Procedural Terminology codes were used to search surveillance imaging procedures. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% CIs for mortality with adjustment for sex, ethnicity, age, health insurance status, cancer site, stage, and treatment. Results The study identified 1004 patients (mean age, 61 years ± 12 [SD]; 753 men), including 902 patients with squamous cell carcinoma (SCC) HNC and 102 patients with non-SCC. The effect of imaging on mortality among patients with SCC was not statistically significant when the entire sample was analyzed (HR, 0.76; 95% CI: 0.57, 1.02;

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsHumansMagnetic Resonance ImagingMaleMiddle AgedPositron Emission Tomography Computed TomographyRetrospective Studies

Identifiers

PMID36625743
PMCPMC10102644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.